title: Sequential rapid oral desensitization to rifampin and moxifloxacin for the treatment of active mycobacterium tuberculosis.
authors.affiliation: Department of Pharmacy Practice, University of Illinois at Chicago College of Pharmacy, Chicago, Ill. Electronic address: benken@uic.edu.
authors.forename: Scott T
authors.initials: ST
authors.lastname: Benken
authors.affiliation: Division of Pulmonary, Critical Care, Sleep, and Allergy, University of Illinois at Chicago College of Medicine, Chicago, Ill.
authors.forename: Sharmilee M
authors.initials: SM
authors.lastname: Nyenhuis
authors.affiliation: Department of Pharmacy Practice, University of Illinois at Chicago College of Pharmacy, Chicago, Ill.
authors.forename: Sean
authors.initials: S
authors.lastname: Dunne
mesh_terms: D000284:Administration, Oral; D000328:Adult; D000485:Allergens / Q000276:immunology / Q000627:therapeutic use*; D000707:Anaphylaxis / Q000209:etiology / Q000517:prevention & control*; D000900:Anti-Bacterial Agents / Q000276:immunology / Q000627:therapeutic use*; D003888:Desensitization, Immunologic / Q000379:methods*; D004342:Drug Hypersensitivity / Q000150:complications / Q000276:immunology / Q000628:therapy*; D064420:Drug-Related Side Effects and Adverse Reactions / Q000276:immunology / Q000628:therapy*; D005260:Female; D006801:Humans; D000077266:Moxifloxacin / Q000276:immunology / Q000627:therapeutic use*; D009169:Mycobacterium tuberculosis / Q000502:physiology*; D012293:Rifampin / Q000276:immunology / Q000627:therapeutic use*; D014376:Tuberculosis / Q000188:drug therapy*; D055815:Young Adult
chemical_list: D000485:Allergens; D000900:Anti-Bacterial Agents; D000077266:Moxifloxacin; D012293:Rifampin